Video Shorts

The Emergence of Histotripsy in Interventional Radiology and Cancer Care

Embracing the Potential of AI in Radiology

Optimizing Radiation Dosing in CT: Three Keys to Success

Why Diagnostics is Finally Getting a Legitimate Seat at the Multidisciplinary Table

Exploring the Potential of AI in Radiology Inside and Outside of the Reading Room

A Challenge to Imaging Specialists on Building Predictive Models in Radiology

A Simplified Dosimetry Approach for Treating GEP-NETs: What New Research Reveals

Can AI Improve Clarity for PI-RADS 3 Assessments on Prostate MRI?

Theranostics: 'The Biggest Advancement in Our Generation When It Comes to Oncology'

Mammography-Based AI Models: Key Takeaways from New Research

How Urinary Excretion Can Facilitate Striking Differences Between PSMA PET Agents

Why Prostatic Artery Embolization Should be a First-Line Treatment for Benign Prostatic Hyperplasia

Could Autonomous AI Lead to 'Dramatic Shifts in Compensation' for Breast Radiologists?

Could Future Research Lead to Personalized Treatment with 177Lu-Edotreotide for GEP-NETs?

Saving AI Output from Mammography Exams Without Causing Unnecessary Patient Worry

Emerging Insights on Embolic Agents for Prostatic Artery Embolization

Balancing 'Ironclad' Clinical Skills with AI Literacy in Radiology Residency Training

Should Breast Radiologists Save AI Output In PACS?

Could AI Deepen the Disparities with Breast Imaging Access?

Keys to Post-Deployment AI Monitoring in Radiology

Can AI Improve Triage and Yield for Breast MRI?

Could Diabetes Be a Key Trigger for Bone Loss and Cognitive Decline?

How the COVID-19 Pandemic Led to Updated BI-RADS Guidance on Addressing Axillary Lymphadenopathy

A Key Advantage of FET PET Over MRI for Glioma Imaging

The Multi-Stakeholder Dilemma with Assessing Value and Costs of AI Integration

Five Takeaways for Breast Radiologists from Guidelines on Proliferative Breast Lesions with Atypia and LCIS

Emphasizing the Need for More Research on Indication-Based DRLs for CT Imaging

Where We Are Seeing Traction with AI Reimbursement for Quantitative Algorithms

Why the PET Agent Floretyrosine F18 is a 'Huge Step Forward' for Glioma Imaging

A 'Wake-Up Call' for BI-RADS 3 Audits